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In this issue of Immunity, Conche et al. (2009) define an antigen-independent signaling pathway that is depen-
dent on cyclic adenosine monophosphate and extracellular signal-regulated kinase and T cells for subse-
quent T cell antigen receptor signaling.Investigators studying lymphocyte activa-
tion often simplify the stimulation process
to their experimental advantage. Those
pursuing biochemical pathways crosslink
the T cell antigen receptor (TCR) and
various coreceptor molecules with mono-
clonal antibodies before cell lysis and
protein isolation. Those who wish to visu-
alize the molecular process of activation
drop cells on antibody-covered surfaces
or planar lipid bilayers doped with appro-
priate molecular ligands. These and other
simplifications have taught us much,
but the more physiological cell-cell
contact of activation has many secrets to
reveal about the events both preceding
and following receptor engagement. A
study byConche et al. (2009) in the current
issue of Immunity elegantly combines
biochemical and molecular imaging
approaches to elucidate an adhesion-
mediated signaling cascade that occurs
prior to TCR ligation, sensitizes the
signaling environment, and leads to more
robust signaling once the TCR is engaged
(Conche et al., 2009).
AdhesionofT cells toartificial substrates
or to dendritic cells (DCs) in the absence
of peptide-MHC complexes triggers a
number of intracellular events that act in
concert to prime the intracellular signaling
environment for subsequent TCR ligation.
Adhesion via integrins triggers recruitment
of signalingandcytoskeletal proteins to the
point of contact (Doucey et al., 2003; Revy
et al., 2001). Adhesion also triggers recruit-
ment of phosphatidylinositol 4,5-bisphos-
phate (PIP2) to the plasma membrane and
increases intracellular calciumstores (Ran-
driamampita et al., 2003). The culmination
of these events, coined adhesion-induced
T cell priming or AITCP (Randriamampita
et al., 2003), prepares the T cell so that,when stimulated via the TCR, it signals
more robustly than does a T cell that did
not receive adhesion signals. The goal
of the study by Conche et al. (2009) was
to define at a molecular level the intracel-
lular signaling pathways responsible for
AITCP.
Conche et al. (2009) made a number of
‘‘educated leaps’’ in elucidating a cyclic
adenosine monophosphate (cAMP)- and
extracellular signal-regulated kinase
(ERK)-dependent pathway required for
AITCP. They first investigated the role of
ERK signaling and showed indeed that
AITCP requires ERK phosphorylation.
Surprisingly, however, adhesion-based
ERK activation was not mediated by its
upstream kinase MAP-ERK kinase (MEK),
but rather by the inhibition of an ERKphos-
phatase. At this point, Conche et al. (2009)
made their first leap and sought a potential
role for cAMP elevation in AITCP, because
ERK and cAMP ‘‘crosstalk’’ in a number of
systems. By using a FRET-based probe
that tracks protein kinase A (PKA) activity,
they showed that there was a transient
rise inPKA (andpresumably cAMP) activity
within 1minof T cell adhesion that returned
tobaselinewithin10min.Byusingacombi-
nation of cAMP analogs and a photoacti-
vatable cAMP, the authors showed that
a transient, but not sustained, rise in
cAMP could substitute for adhesion in
‘‘priming’’ T cells, and that both the timing
and amplitude of the cAMP signal were
important for maximal TCR-mediated
signaling. Furthermore, inhibition of cAMP
signaling blocked adhesion-induced ERK
activation, showing that ERK was down-
stream of cAMP in AITCP.
To mechanistically tie cAMP and ERK
signaling together, Conche et al. (2009)
made their second leap and investigatedImmunitythe role of HePTP, an ERK phosphatase
that can be phosphorylated and inacti-
vated by PKA downstream of TCR
signaling (Nika et al., 2004). Knockdown
of HePTP increased basal ERK activation
and substituted for adhesion in potenti-
ating TCR-induced calcium flux. These
data suggested that HePTP could be the
physiologic target of cAMP-PKA in
AITCP. Conche et al. (2009) then returned
to imaging studies to validate their
signaling model in vivo. The interaction
of T cells with DCs in the absence of
antigen showed transient increases in
PKA activity by FRET and specific phos-
pho-ERK staining at the T-DC interface.
Both signals were sensitive to cAMP
pathway inhibition. Furthermore, simulta-
neous live-cell imaging of PKA activity
and calcium flux showed that the tran-
sient rise in cAMP preceded the calcium
signal, giving further evidence that the
cAMP signal is an initiating event after
T-DC contact. Finally, they showed that
in the presence of antigen, simultaneous
blocking of adenylate cyclase (AC) and
PKA reduced calcium flux, NF-AT trans-
location, and CD69 expression. Thus,
Conche et al. (2009) proposed a model
that upon T cell-DC contact and prior to
TCR ligation, there was a transient rise
in cAMP-PKA signaling that led to ERK
activation via PKA-mediated inactivation
of the ERK phosphatase HePTP (Figure 1,
left).
A number of questions arise, however,
when one tries to integrate cAMP-medi-
ated AITCP into our current under-
standing of TCR signal transduction. It is
well established that cAMP-PKA can
have a negative effect on TCR signaling.
cAMP is generated via AC and is inacti-
vated by phosphodiesterases (PDEs).30, January 16, 2009 ª2009 Elsevier Inc. 3
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PreviewsStimulation of the TCR increases localized
cAMP concentrations, activating PKA
that is bound to the cytoplasmic adaptor
A-kinaseanchoringprotein (AKAP).AKAPs
nucleate large signaling complexes
that include PKA and the inhibitory kinase
Csk and are required for maximal activa-
tion of Csk by PKA. Csk can then phos-
phorylate and inactivate Lck, inhibiting
proximal TCR signaling. This inhibitory
cAMP-PKA signaling is blocked, however,
by costimulation via CD28. CD28 recruits
PDEs via the adaptor b-arrestin, within
proximity to the AKAP-scaffolded signalo-
some, allowing cAMP activity to be held in
check (Ruppelt et al., 2007; Tasken and
Stokka, 2006).
How does the unique positive role for
cAMP reported by Conche et al. (2009)
fit with the current understanding of
cAMP-PKA as a negative regulator of
TCR signaling? Conche et al. (2009)
suggest that the answer may lie in the
quality of the cAMP signal. The transient,
low-amplitude response triggered by
adhesion may be sufficient to inactivate
HePTP but not to activate Csk, whereas
sustained increases in cAMP can engage
AKAP-scaffolded Csk complexes to
inhibit T cell signaling (Figure 1, right; Rup-
pelt et al., 2007). Alternatively, AITCP and
TCR signaling may engage different pools
of either adenylate cyclase or of cAMP
effectors. If so, the local signaling environ-
ment could then exert tremendous control
over the outcome of cAMP-PKA signaling.
Furthermore, local control of cAMP can
be directly exerted by PDE activity. PDE
activity, in turn, is regulated through direct
phosphorylation both positively by PKA
and negatively by ERK (Tasken and
Stokka, 2006). AKAPs can simultaneously
interact with PKA and PDE (Asirvatham
et al., 2004), which allows for rapid spatial
and temporal regulation of cAMP activity.
The localized control of cAMP signaling in
both AITCP and TCR signaling, and how
these competing signals may overlap,
are important open questions.
So how do the positive and negative
signals generated by cAMP modulate
TCR-induced calcium signaling? One
attractive target is the Src kinase Lck,
which is sensitive to both positive and
negative regulatory signals (Stefanova
et al., 2003; Tasken and Stokka, 2006).
Thus, transient cAMP signals could
increase ERK activation, allowing ERK to
phosphorylate Lck on Ser59, releasing
Lck from negative regulation by the tyro-
sine phosphatase Shp-1. More activated
Lck might lead to enhanced calcium flux
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Figure 1. The Dual Roles of cAMP in T Cell Signaling
Adhesion (AITCP) triggers a transient increase in cAMP-PKA activity. PKA then phosphorylates and inac-
tivates the ERK phosphatase HePTP, leading to a transient rise in ERK activation (left). In contrast (right),
TCR activation or other stimuli (diphtheria toxin, cholera enterotoxin, forskolin, PGE2, etc.) trigger strong,
sustained cAMP-PKA activity. This degree of stimulation induces PKA phosphorylation and activation of
the inhibitory kinase Csk on AKAP-Ebp50-Cbp scaffolded complexes. The action of TCR-inducted cAMP
can be antagonized, however, by CD28 costimulation via recruitment of PDEs (far right). Both cAMP path-
ways may ultimately effect TCR signal transduction via, among other mechanisms, the modulation of Lck
activity. cAMP pathways that enhance TCR signaling are shown in blue, those that diminish signaling are
shown in red.4 Immunity 30, January 16, 2009 ª2009 Elsevier Inc.(Lovatt et al., 2006). Alternatively, sus-
tained cAMP signaling increases Csk
activity, allowing Csk to phosphorylate
Lck on Tyr505 and causing the SH2
domain of Lck to fold back on itself, result-
ing in its inactivation (Figure 1). Whether
either or both of these mechanisms,
however, are relevant to cAMP signaling
in vivo remains to be seen.
A number of questions also remain in
understanding the generation of AITCP
signals. Randriamampita et al. (2003)
had previously reported that adhesion
triggered recruitment of PIP2 to the
plasma membrane and increased intra-
cellular calcium stores. Although it is
easy to understand how these changes
enhance the intracellular signaling envi-
ronment for maximal output, it is unclear
how these signals are generated. Are
they downstream of a cAMP-ERK
pathway, or does adhesion trigger addi-
tional signals to account for these
changes? This question remains open,
as does the looming question of how
cAMP is initially generated downstream
of adhesion.
Finally, what is the in vivo conse-
quence of AITCP? Conche et al. (2009)
suggest that cAMP-dependent sensitiza-
tion occurs in lymph nodes. If this is so,
can manipulation of a cAMP-ERK signal-
ing pathway modulate T cell responsive-
ness to low potency ligands, and could
the ability to modulate immune responses
be harnessed therapeutically? Although
these questions seem much more diffi-
cult to address, they are critical for the
in vivo validation of AITCP signaling, and
to integrate this unique signaling pathway
into our understanding of immune cell
function.
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cells from differentiating into dendri
thymus arose from a cell-extrinsic p
For some yearswehavebeen aware of the
role of Notch signaling in T cell lineage
commitment. The common tenor of early
studies is that interference with Notch
signaling in early hemopoietic or T cell
development results in abolition of the
T cell lineage and vastly increased
numbers of thymic B cells by unknown
mechanisms. In this issue of Immunity,
Feyerabend et al. (2009) report on a
powerful approach that combines condi-
tional Notch 1 ablation in pro-T cells with
lineage fate mapping to conclude that
Delta-like 4 (Dll4)-inducedNotch signaling
is required to keep pro-T cells on track to
differentiate into T cells, preventing their
diversion into dendritic cells (DCs) and
B cells. Interestingly, Notch1 deficiency in
pro-T cells results in accumulation of
thymic B cells by cell-intrinsic as well
as -extrinsic mechanisms.
In lineage fate-mapping studies, Feyer-
abend et al. (2009) employed knockin
mice, in which the cre-recombinase was
expressed under control of the promoter
of the Cpa3 gene (Reynolds et al., 1989)
that encodes the mast cell carboxypepti-
dase a (Mc-cpa). The recombinase could
then activate a red fluorescent protein
(RFP) reporter by elimination of a floxed
stop cassette, thereby tracking the ex-
pression of Cpa3. The reporter was ex-
pressed in about 90% of T cells but only
marginally in B cells. Like other mast
cell-specific genes, Cpa3 is expressed inRevy, P., Sospedra, M., Barbour, B., and Traut-
mann, A. (2001). Nat. Immunol. 2, 925–931.
Ruppelt, A., Mosenden, R., Gronholm, M., Aan-
dahl, E.M., Tobin, D., Carlson, C.R., Abrahamsen,
H., Herberg, F.W., Carpen, O., and Tasken, K.
(2007). J. Immunol. 179, 5159–5168.-T Cells on Track
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d et al. (2009) report that Delta-like 4
tic cells and B cells. In addition, in th
athway.
pro-T but not mature T cells (Taghon
et al., 2007), providing a rational explana-
tion for the fate-mapping results. Closer
inspection revealed that about 25% of
the most immature c-Kit+ Flt3+ and about
45% of c-Kit+ thymic pro-T cells were
RFP+ increasing up to 90% in DN2 thymo-
cytes, consistent with the view that the
reporter came on in the earliest thymic
pro-T cells after B cell potential was extin-
guished. This enabled the authors to
conduct elegant studies by conditional
ablation of Notch 1 combined with fate
mapping to study the role of Notch 1 in T
lineage fate.
The lineage fate-mapping studiesdocu-
ment that under physiological conditions,
pro-T cells (at least the ones that express
Mc-cpa) do not ‘‘spin off’’ DCs because
DCsof all subsets, i.e., lymphoid,myeloid,
or plasmacytoid, whether from spleen or
thymus, exhibited similar frequencies of
RFP+ cells, which were lower than among
c-Kit+ pro-T cells. Had the thymic DCs
been derived from Mc-cpa-expressing
pro-T cells, their frequency of RFP+ cells
should have been much higher than that
among peripheral DCs. However, under
nonphysiological conditions, pro-T cells
can differentiate into DCs in vitro (Bell
and Bandhoola, 2008) Thus, intrathymic
DCs may normally be derived from very
early Mc-cpa-negative thymic pro-T cells
or from precursors unrelated to the T cell
lineage. Because the normal thymus
ImmunityStefanova, I., Hemmer, B., Vergelli, M., Martin, R.,
Biddison, W.E., and Germain, R.N. (2003). Nat.
Immunol. 4, 248–254.
Tasken, K., and Stokka, A.J. (2006). Biochem. Soc.
Trans. 34, 476–479., acting on Notch 1, prevents pro-T
e absence of Notch 1, B cells in the
contains very few B cells, their origin is of
lesser physiological relevance.
The fate-mapping results change dras-
tically when Notch 1 is deleted in pro-
T cells. Under these conditions, the
proportion of RFP-expressing DCs of all
subsets increased inside but not outside
the thymus, indicating that this increase
was due to pro-T cell-derived DCs. More-
over, the number of thymic B cells
increased drastically but the majority of
B cells did not appear to be derived from
Notch1-deficient pro-T cells because
most CD19hi B cells had not deleted their
Notch1 alleles as detected by single-cell
PCR. In contrast to this newly recognized
cell-extrinsic pathway, Notch1 was quan-
titatively deleted in the majority of CD19lo
B cells. Consistent with this notion, RFP-
labeling frequencies were also higher in
CD19lo B cells than in CD19hi B cells
(Figure 1). These data were not shown
because RFP-labeling frequencies did
not reach the frequencies observed for
Notch1 deletion, indicating that Mc-cpa-
Cre acted more efficiently on the floxed
Notch1 allele than on the floxed RFP allele
in the ROSA locus. The authors therefore
considered the Notch1 genotype as the
most direct molecular evidence for fate
conversion of Notch1-deleted pro-T cells
to thymic B cells. Only a minor subset of
CD19lo B cells exhibits deletion of both
Notch 1 alleles and hence drives their
conversion from the pro-T cell lineage.
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